HIM
NVRO

Hillsdale Investment Management’s NEVRO CORP. NVRO Stock Holding History

Hillsdale Investment Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,400
Closed -$1.03M – 669
2020
Q3 		$1.03M Buy
7,400
+1,400
+23% +$187K 0.1% 175
2020
Q2 		$717K Sell
6,000
-24,300
-80% -$2.88M 0.07% 259
2020
Q1 		$3.03M Buy
+30,300
New +$3.64M 0.36% 69

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hillsdale Investment Management's NVRO Position: Q4 2020 in Review

Hillsdale Investment Management sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 7,400 shares — an estimated $1.03M sold.

Hillsdale Investment Management first reported a position in NVRO in Q1 2020 and held it in 3 quarters. The position peaked at $3.03M in Q1 2020. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

  • Hillsdale Investment Management reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
  • Hillsdale Investment Management sold 7,400 NEVRO CORP. shares in Q4 2020, an estimated $1.03M.
  • Hillsdale Investment Management first reported a position in NEVRO CORP. in Q1 2020 and held it in 3 quarters.
  • Hillsdale Investment Management's NEVRO CORP. position peaked at $3.03M in Q1 2020.
  • 226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Hillsdale Investment Management's 13F filing for Q4 2020, filed 9 Feb 2021.